How many institutions held IRD - Opus Genetics, Inc. - Common Stock, $0.0001 par value per share in Q4 2025?

58 institutional investors reported IRD - Opus Genetics, Inc. - Common Stock, $0.0001 par value per share for Q4 2025. Use the holders table for investor-level position and value details.

Opus Genetics, Inc. - Common Stock, $0.0001 par value per share (IRD)

Q: What does CUSIP 67577R102 represent in this 13F holders report?

CUSIP 67577R102 is the security identifier for IRD - Opus Genetics, Inc. - Common Stock, $0.0001 par value per share used to aggregate holder disclosures.

CUSIP: 67577R102

Q4 2025 13F Holders as of 31 Dec 2025

Type / Class: Equity / Common Stock, $0.0001 par value per share
Shares outstanding: 81,311,898
Total 13F shares: 27,812,069
Share change: +8,771,323
Total reported value: $55,903,061
Price per share: $2.01
Number of holders: 58
Value change: +$17,653,005
Number of buys: 33
Number of sells: 13

Quarterly Holders Quick Answers

What is CUSIP 67577R102?
CUSIP 67577R102 identifies IRD - Opus Genetics, Inc. - Common Stock, $0.0001 par value per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q1 2026
Previous quarter: Q3 2025

Recent filing periods for CUSIP 67577R102:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Top shareholders of IRD - Opus Genetics, Inc. - Common Stock, $0.0001 par value per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
PERCEPTIVE ADVISORS LLC	13D/G 13F	Company	10%	7,174,154	$14,420,050	+$5,353,943	31 Dec 2025	13D/G 13F
Nantahala Capital Management, LLC	13D/G 13F	Company	10%	7,123,506	$14,318,247	+$1,755,146	31 Dec 2025	13D/G 13F
Foundation Fighting Blindness Retinal Degeneration Fund	3/4/5 13D/G	Director, Other*	8% from 13D/G	5,492,171	$11,808,167	-$8,600,000	09 Dec 2025	3/4/5 13D/G
BALYASNY ASSET MANAGEMENT L.P.	13D/G	—	7.4%	5,110,373	$10,271,850	$0	31 Dec 2025	13D/G
BIOS Capital Management, LP	13F	Company	— mixed-class rows	5,374,180 mixed-class rows	$8,537,702	—	30 Sep 2025	13F
BIOS Fund III, LP	13D/G	BIOS EQUITY PARTNERS III, LP	6.2%	3,683,429	$5,156,801	$0	05 May 2025	13D/G
Voss Capital, LP	13F	Company	— mixed-class rows	3,228,909 mixed-class rows	$3,981,101	—	30 Sep 2025	13F
VANGUARD GROUP INC	13F	Company	— mixed-class rows	2,510,432 mixed-class rows	$3,552,167	—	30 Sep 2025	13F
Mink Brook Asset Management LLC	13F	Company	1.5%	1,237,947	$2,042,613	—	30 Sep 2025	13F
Opaleye Management Inc.	13F	Company	1.4%	1,100,000	$1,815,000	—	30 Sep 2025	13F
ADAGE CAPITAL PARTNERS GP, L.L.C.	13F	Company	1.2%	954,996	$1,575,743	—	30 Sep 2025	13F
Bleichroeder LP	13F	Company	0.91%	736,842	$1,215,789	—	30 Sep 2025	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	— mixed-class rows	716,248 mixed-class rows	$1,057,093	—	30 Sep 2025	13F
Prosight Management, LP	13F	Company	0.73%	567,898	$650,243	—	30 Sep 2025	13F
UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO	13F	Company	0.66%	511,610	$585,793	—	30 Sep 2025	13F
Cable Car Capital, LP	13F	Company	0.54%	420,000	$480,900	—	30 Sep 2025	13F
Jay Pepose	3/4/5	Director	— mixed-class rows	215,639 mixed-class rows	$318,508	—	11 Jun 2024	3/4/5
RENAISSANCE TECHNOLOGIES LLC	13F	Company	— mixed-class rows	192,107 mixed-class rows	$307,736	—	30 Sep 2025	13F
Ronil A. Patel	3/4/5	Chief Business Officer	— mixed-class rows	165,252 mixed-class rows	$296,181	—	10 Jan 2024	3/4/5
Sigma Planning Corp	13F	Company	0.33%	253,827	$290,632	—	30 Sep 2025	13F
Senvest Management, LLC	13F	Company	0.3%	230,895	$264,375	—	30 Sep 2025	13F
GAGNON SECURITIES LLC	13F	Company	0.29%	228,692	$261,852	—	30 Sep 2025	13F
STATE STREET CORP	13F	Company	— mixed-class rows	161,877 mixed-class rows	$259,015	—	30 Sep 2025	13F
Nirav S. Jhaveri	3/4/5	Chief Financial Officer	— mixed-class rows	246,793 mixed-class rows	$223,437	—	13 Mar 2025	3/4/5
CITADEL ADVISORS LLC	13F	Company	— mixed-class rows	141,617 mixed-class rows	$219,426	—	30 Sep 2025	13F
Bernhard Hoffmann	3/4/5	SVP of Corp. Dev.	— mixed-class rows	214,946 mixed-class rows	$213,263	—	13 Mar 2025	3/4/5
Creative Planning	13F	Company	0.16%	128,366	$211,804	—	30 Sep 2025	13F
TWO SIGMA INVESTMENTS, LP	13F	Company	0.13%	108,338	$178,758	—	30 Sep 2025	13F
Mina Sooch	3/4/5	President and CEO, Director	— class O/S missing	50,000	$163,250	—	10 Jan 2023	3/4/5
NORTHERN TRUST CORP	13F	Company	— mixed-class rows	93,991 mixed-class rows	$142,075	—	30 Sep 2025	13F
BlackRock, Inc.	13F	Company	— mixed-class rows	98,968 mixed-class rows	$136,595	—	30 Sep 2025	13F
XTX Topco Ltd	13F	Company	— mixed-class rows	66,741 mixed-class rows	$102,556	—	30 Sep 2025	13F
BRIDGEWAY CAPITAL MANAGEMENT, LLC	13F	Company	0.05%	42,065	$69,407	—	30 Sep 2025	13F
Empowered Funds, LLC	13F	Company	0.05%	42,065	$69,407	—	30 Sep 2025	13F
SUSQUEHANNA INTERNATIONAL GROUP, LLP	13F	Company	— mixed-class rows	51,073 mixed-class rows	$68,686	—	30 Sep 2025	13F
BLAIR WILLIAM & CO/IL	13F	Company	— mixed-class rows	47,859 mixed-class rows	$67,154	—	30 Sep 2025	13F
SIMPLEX TRADING, LLC	13F	Company	0.04%	32,847	$54,000	—	30 Sep 2025	13F
CAPTRUST FINANCIAL ADVISORS	13F	Company	0.04%	32,000	$52,800	—	30 Sep 2025	13F
KCK LTD.	13F	Company	0.03%	22,341	$52,055	—	30 Sep 2025	13F
NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO	13F	Company	0.05%	42,440	$48,594	—	30 Sep 2025	13F
MORGAN STANLEY	13F	Company	0.04%	28,606	$47,200	—	30 Sep 2025	13F
Chicago Partners Investment Group LLC	13F	Company	0.04%	31,048	$40,983	—	30 Sep 2025	13F
RAYMOND JAMES FINANCIAL INC	13F	Company	0.03%	22,508	$37,138	—	30 Sep 2025	13F
EXENCIAL WEALTH ADVISORS, LLC	13F	Company	0.04%	30,528	$34,955	—	30 Sep 2025	13F
HRT FINANCIAL LP	13F	Company	0.03%	20,677	$34,000	—	30 Sep 2025	13F
Meridian Wealth Advisors, LLC	13F	Company	0.04%	28,486	$32,616	—	30 Sep 2025	13F
KESTRA PRIVATE WEALTH SERVICES, LLC	13F	Company	0.02%	19,000	$31,350	—	30 Sep 2025	13F
Texas Capital Bank Wealth Management Services Inc	13F	Company	0.03%	26,171	$29,966	—	30 Sep 2025	13F
TWO SIGMA SECURITIES, LLC	13F	Company	0.02%	17,746	$29,281	—	30 Sep 2025	13F
JAMES INVESTMENT RESEARCH, INC.	13F	Company	0.02%	16,364	$27,001	—	30 Sep 2025	13F

Institutional Holders of Opus Genetics, Inc. - Common Stock, $0.0001 par value per share (IRD) as of Q4 2025

As of 31 Dec 2025, Opus Genetics, Inc. - Common Stock, $0.0001 par value per share (IRD) was held by 58 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 27,812,069 shares. The largest 10 holders included Nantahala Capital Management, LLC, PERCEPTIVE ADVISORS LLC, BIOS Capital Management, LP, Balyasny Asset Management L.P., VANGUARD GROUP INC, MILLENNIUM MANAGEMENT LLC, Mink Brook Asset Management LLC, Opaleye Management Inc., ADAGE CAPITAL PARTNERS GP, L.L.C., and Bleichroeder LP. This page lists 58 institutional shareholders reporting positions in this security for the Q4 2025 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q4 2025 vs Q3 2025 Across Filers

Q3 2025 holders

Q4 2025 holders

Holder diff

Investor	Q3 2025 Shares	Q4 2025 Shares	Share Diff	Share Chg %	Q3 2025 Value $	Q4 2025 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.